By 2032, it is anticipated that the Ankylosing Spondylitis Treatment Market would reach US$5.1409 billion. Through 2032, the market for treating ankylosing spondylitis is anticipated to grow at a CAGR of 4.6%. The market for treating ankylosing spondylitis is anticipated to reach US$ 8.06 billion in 2022. The market for treating ankylosing spondylitis is projected …
Category Archives: Healthcare Trends
Manual Resuscitator Market is expected to increase US$ 845.3 Million by 2030 at a 5.7% CAGR
According to research by ESOMAR-certified company Future Market Insights, the global Manual Resuscitator Market is expected to reach a valuation of USD 845.3 million by 2030, is expected to register a CAGR of 5.7% over the forecast period (2022 – 2030). (FMI). in a recent market research. Breathlessness is the first symptom of COPD (chronic obstructive pulmonary …
Vaginal and Vulval Inflammatory Disease Treatment Market is likely to register CAGR of 5.8% by 2033
The Global Vaginal and Vulval Inflammatory Disease Treatment Market Size is predicted to grow to US$2.96 billion in the fiscal year 2023, up from US$2.8 billion in 2022. The market is expected to have a steady growth rate of 5.8% CAGR between 2023 and 2033, ultimately reaching a value of US$5.21 billion by the end …
Portal Hypertension Management Market to reach US$ 4.97 billion by 2033, at a CAGR of 5%
According to a report by Future Market Insights, the global market for portal hypertension management is expected to reach a value of US$ 3.05 billion in 2023. The market is projected to grow at a compound annual growth rate (CAGR) of 5% from 2023 to 2033. Currently, the generic pharmaceutical segment is leading the market, …
By 2032 Injectable Benzodiazepine Market sales are likely to reach US$ 356 Million grow at a 2.7% CAGR
Sales of Injectable Benzodiazepine Market are predicted to reach $274 million by the end of 2022. Sales of injectable benzodiazepines are predicted to reach US$ 356 million by 2032’s end. From 2022 to 2032, the injectable benzodiazepines market is anticipated to expand at a 2.7% CAGR. Global Injectable Benzodiazepine Market sales are set to reach …
Clinical Oncology Next-generation Sequencing Market reaching a valuation of US$ 1.14 Billion by 2029 at a prolific CAGR of 16.3%
The Clinical Oncology Next-generation Sequencing Market is anticipated to reach US$ 449.4 Mn in value by 2022. The total market is anticipated to grow at a remarkable CAGR of 16.3% between 2022 and 2029, reaching a valuation of US$ 1.14 Bn by 2029, due to the increasing implementation of next generation sequencing (NGS) in clinical …
Antidiabetics Market in the United States is anticipated to garner US$ 79.6 Billion by 2032 | FMI Study
The global Antidiabetics Market is expected to reach US$ 89.2 billion in 2022, up from US$ 80.4 billion in 2021, with a Y-o-Y growth rate of 10.9%. The industry is expected to reach US$ 223 billion by 2032, with a CAGR of 9.6% between 2022 and 2032. The rising global prevalence of diabetes is expected …
Preclinical Medical Device Testing Services Market is expected to reach a valuation of US$ 6.3 Billion by 2032 | FMI
The global Preclinical Medical Device Testing Services Market was worth US$ 2.8 billion in 2022 and is expected to be worth US$ 6.63 billion by 2032, growing at a CAGR of 9% during the forecast period. Preclinical medical device testing services market growth can be attributed to increasing product complexity and stringent government regulations. The …
Cirrhosis Management Market is expected to grow at a 3.8% CAGR between 2022 and 2032 | FMI
The global Cirrhosis Management Market, which was worth US$ 701.8 million in 2022, is expected to grow at a CAGR of 3.8% between 2022 and 2032, reaching US$ 1,059 million. From 2016 to 21, the market grew at a compounded annual rate of 3.5%. The market’s expansion can be attributed to the rising incidences of …
Clinical Decision Support Systems Market is predicted to advance at a CAGR of 10.4% from 2023 to 2033 | FMI
It is predicted that during the forecast period, the global market for Clinical Decision Support Systems will grow at a moderate rate of 10.4%. Clinical decision support systems will be worth US$ 5.46 billion in 2023, according to the market valuation at the moment. By the year 2033, it is predicted that the market for …